4.4 Article

The perlecan heparan sulfate proteoglycan mediates cellular uptake of HIV-1 Tat through a pathway responsible for biological activity

Journal

VIROLOGY
Volume 330, Issue 2, Pages 481-486

Publisher

ACADEMIC PRESS INC ELSEVIER SCIENCE
DOI: 10.1016/j.virol.2004.10.011

Keywords

human immunodeficiency virus type 1; Tat; heparan sulfate proteoglycans; long terminal repeat

Categories

Funding

  1. NHLBI NIH HHS [HL56984, HL58884] Funding Source: Medline
  2. NIAID NIH HHS [AI46149, AI41899] Funding Source: Medline
  3. NINDS NIH HHS [NS27405, NS44513] Funding Source: Medline

Ask authors/readers for more resources

Cell surface heparan sulfate proteoglycans (HSPGs) mediate internalization of HIV-1 Tat. Herein, we report that human WiDr cells, which express perlecan but no other HSPGs, can internalize I-125-labeled Tat with minimal lysosomal degradation. Pre-treatment of cells with heparitinase almost completely abolished I-125-Tat surface binding, while the use of an HIV-1 long terminal repeat (LTR) promoter-reporter construct demonstrated that transactivation was potently blocked by pretreatment of cells with heparitinase, indicating an essential role for perlecan in the biologic effects of Tat. We conclude that the perlecan mediates Tat uptake and is required for HIV-1 LTR-directed transactivation in this human cell type. (C) 2004 Elsevier Inc. All rights reserved.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.4
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available